Efficacy and Safety of a Single-Pill Triple Combination of Olmesartan, Amlodipine, and Rosuvastatin in Hypertensive Patients with Low-to-Moderate Cardiovascular Risk: A Multicenter, Randomized, Open-Label, Active-Control, Phase IV Clinical Trial

Efficacy and Safety of a Single-Pill Triple Combination of Olmesartan, Amlodipine, and Rosuvastatin in Hypertensive Patients with Low-to-Moderate Cardiovascular Risk: A Multicenter, Randomized, Open-Label, Active-Control, Phase IV Clinical Trial

Introduction This study evaluated the efficacy and safety of a single-pill triple-combination of olmesartan/amlodipine/rosuvastatin (Olme/Amlo/Rosu) in comparison with a single-pill dual-combination of olmesartan/amlodipine (Olme/Amlo) in hypertensive patients with low-to-moderate cardiovascular ris...

Full description

Bibliographic Details
Main Authors: Byung Jin Kim MD, PhD, Kwang Soo Cha MD, PhD, Wook Hyun Cho MD, PhD, Eung Ju Kim MD, PhD, Seung-Hyuk Choi MD, PhD, Moo Hyun Kim MD, PhD, Sang-Hyun Kim MD, PhD, Jun-Bean Park MD, PhD, Seong-Mi Park MD, PhD, Il Suk Sohn MD, PhD, Kyu Hyung Ryu MD, PhD, In-Ho Chae MD, PhD
Format: Article
Language:English
Published: SAGE Publishing 2023-10-01
Series:Journal of Cardiovascular Pharmacology and Therapeutics
Online Access:https://doi.org/10.1177/10742484231205204

Internet

https://doi.org/10.1177/10742484231205204

Similar Items